364 related articles for article (PubMed ID: 35887337)
1. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
2. microRNA in inflammatory bowel disease at a glance.
Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
7. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
8. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
9. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
[TBL] [Abstract][Full Text] [Related]
11. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
[TBL] [Abstract][Full Text] [Related]
12. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models.
Suri K; Bubier JA; Wiles MV; Shultz LD; Amiji MM; Hosur V
Cells; 2021 Aug; 10(9):. PubMed ID: 34571853
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease.
Heydari R; Karimi P; Meyfour A
Biomed Pharmacother; 2024 Jul; 176():116868. PubMed ID: 38850647
[TBL] [Abstract][Full Text] [Related]
14. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S
Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Inflammatory Bowel Disease and Its Complications.
Krishnachaitanya SS; Liu M; Fujise K; Li Q
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955886
[TBL] [Abstract][Full Text] [Related]
16. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
[TBL] [Abstract][Full Text] [Related]
17. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.
Ghafouri-Fard S; Eghtedarian R; Taheri M
Biomed Pharmacother; 2020 Sep; 129():110507. PubMed ID: 32768980
[TBL] [Abstract][Full Text] [Related]
18. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers.
Luo S; Chen XH
Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
[TBL] [Abstract][Full Text] [Related]
20. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
